Updated:
AI device changes after approval: what a PCCP means
FDA lists an August 2025 final guidance on predetermined change control plans for AI-enabled devices. What it is, and what a hospital should ask.
Most hospital equipment stays the same after you buy it. AI software may not. A model can be retrained or updated, and then it is no longer exactly the product you reviewed. FDA has a mechanism for authorizing some of those changes in advance, and a hospital buyer should know it exists.
What a PCCP is
FDA’s page on predetermined change control plans (PCCPs) describes a PCCP as a plan that describes certain planned changes that may be made to a device. It also covers how the manufacturer will develop, test and implement those changes and assess their impact. A manufacturer can include a PCCP in a marketing submission so FDA can authorize future changes in advance. The page says those changes can then be made without a new submission for each one.
The same page lists a final guidance dated August 2025 titled Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions. It also lists a separate draft guidance from August 2024 on PCCPs for medical devices more broadly, which is a draft and not final.
What this means on the hospital side
A PCCP is a tool for manufacturers. It does not tell you whether a given model update is good for your patients. What it does give you is a set of questions that are specific and answerable:
- Does this device have an authorized PCCP? If so, which kinds of change does it cover?
- How will we be told when a change is made under the plan?
- How will we check that the tool still performs as expected in our hospital after a change?
If a vendor cannot say whether a PCCP exists, that is information too. It may mean the product is not an authorized device, or that the vendor has not thought about change management. Either way, put the question in the contract review.
Do not confuse this with a hospital’s own monitoring
FDA’s mechanism concerns what the manufacturer may change. It does not take over the hospital’s job of watching performance in its own setting. Decide who in your organization looks at the tool’s results after go-live, and what happens when they look worse than expected.
Key takeaways
- A PCCP describes planned device changes and how they will be developed, tested and implemented, so FDA can authorize them in advance.
- FDA’s page lists a final guidance dated August 2025 for AI-enabled device software functions.
- Ask a vendor whether the device has a PCCP, what it covers, and how you will be told of changes.
- A PCCP does not replace your own monitoring after go-live.